Although it has not been shown in ovarian cancers that estrogen and ER are involved in tumor proliferation in a similar manner to breast cancers, an effect of AIs on ER-positive ovarian cancer can be expected based on the results of this study, which demonstrated inhibition of tumor proliferation in ERα-positive ovarian cancers by the AI. Here, ESR1 is linked to breast carcinoma.